MDS Podcast

International Parkinson and Movement Disorder Society
undefined
Mar 7, 2022 • 0sec

Overview and core components of the peer review process

For the first episode of the special series focused on the peer review process, Dr. Daniel Di Luca speaks with Dr. Christopher Goetz about the importance and most important aspects of a peer review.
undefined
Feb 15, 2022 • 0sec

Neuropsychiatric features of punding and hobbyism in Parkinson's disease

Dr. Hugo Morales discusses "Neuropsychiatric Features of Punding and Hobbyism in Parkinson’s Disease," by Dr. Pedro Barbosa et al., from Movement Disorders Clinical Practice. Read the article.
undefined
Jan 17, 2022 • 0sec

Approach to neuroimaging in Parkinsonisms

Dr. Sara Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in Movement Disorders Clinical Practice on a "Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms." Read the article
undefined
Dec 13, 2021 • 0sec

Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology

Dr. Günter Hoglinger discusses the article he recently published in the Movement Disorders journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations. Read the article
undefined
Oct 18, 2021 • 0sec

The most impactful paper related to movement disorders therapy in the 20th century

Dr. Sara Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today. Read the article
undefined
Oct 18, 2021 • 0sec

Variability of movement disorders: The influence of sensation

Dr. Michele Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders journal, highlighting the impact on several factors on the variability of movement disorders. Read the article
undefined
Oct 18, 2021 • 0sec

Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target?

Dr. Michele Matarazzo speaks with Prof. Ryosuke Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression. Read the article
undefined
Oct 18, 2021 • 0sec

Swim for Parkinson: Swimming together to improve together

The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD.
undefined
Sep 30, 2021 • 0sec

An interview with Claudia Trenkwalder | Congress 2021

Dr. Sara Schaefer discusses with Dr. Claudia Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.
undefined
Sep 1, 2021 • 0sec

Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients

Dr. Sara Schaefer speaks with Dr. Anumantha Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease. Read the article

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app